UNIVERSITÀ DEGLI STUDI DI TORINO

Provider: Università degli Studi di Torino - (ID 173)

19th EUROPEAN SOCIETY FOR HAEMAPHERESIS AND HAEMOTHERAPY (ESFH) CONGRESS

Obiettivo n° 1: Applicazione nella pratica quotidiana dei principi e delle procedure dell’evidence based practice (ebm – ebn – ebp)

Palazzo dei Congressi - Piazza Adua, 1 - Firenze

19 MAGGIO 2014 14.00 - 18.30 Titolo/argomento Relatori

14.00 - 14.30 Opening Remaks

14.30 - 15.15 Lecture - Clinical Apheresis: state of the art Gail Rock

(Luca Pierelli)

15.15 - 15.40 Peripheral blood stem cell procurement as

standard treatment for hematologic malignancies Rainer Moog

(Alessandro Lanti)

15.40 - 16.05 Lymphocyte collection for DLI and Adoptive

Immunotherapy Alberto Bosi (Luca Pierelli)

16.05 - 16.30 PBSC Collection technologies and graft

composition Boris Calmels (Alberto Bosi)

16.30 - 16.45

COFFEE BREAK

16.45 - 17.10 Immune effector clinical depletion in

haploidentical transplant Sergio Rutella (Alberto Bosi)

17.10 - 17.35 Improving the autologous graft by optimizing

cryprotectant and cell washing Riccardo Saccardi

(Luca Pierelli)

17.35 - 18.00 Collection, Expansion and Clinical use of MSC Paola Iudicone (Alberto Bosi)

18.00 - 18.25 Clinical estimation of PBSC content in

frozen/thawed products Francesco Lanza

(Luca Pierelli)

18.25 - 18.30 Discussion

20 MAGGIO 2014 8.30 - 12.00 Titolo/argomento Relatori

8.30 - 8.55 Regulatory Aspects in Apheresis Medicine: International Perspective and Challenges

Chester Jr. Andrzejewski (Luca Pierelli)

8.55 - 9.20 Outcome of JACIE standard application in

collection and processing units Eoin McGrath

(A. Bosi)

9.20 - 9.45 A working hypotesis: a sectorial standard for

therapeutic apheresis Miguel Lozano (Luca Pierelli)

9.45 - 10.00 Discussion 10.00 - 10.30

COFFEE BREAK

10.30 - 10.55 Donor’s care and laboratory examinations in

donor apheresis John Laura Infanti

(Luca Pierelli)

10.55 - 11.20 Donor Apheresis technologies in the third

millennium Jeffrey Lawrence Winters

(Luca Pierelli)

11.20 - 11.45 Blood Donation and Donor Apheresis in Europe:

the search for the “Golden Proportion” Hans Vrielink (Luca Pierelli)

11.45 - 12.00 Discussion

14.00 - 18.00 Titolo/argomento Relatori

14.00 - 14.25 Continuous promotion of clinical evidences and

appropriateness in therapeutic apheresis Zbigniew Szczepiorkowski

(Luca Pierelli)

14.25 - 14.50 Emergent indications in therapeutic apheresis Paolo Perseghin

(Luca Pierelli)

14.50 - 15.15 To imagine a role for ECP in GVHD prophylaxis Andrea Bacigalupo

(Luca Pierelli)

15.15 - 15.30 Discussion

16.00 - 17.30 Presentation of 8 oral communications Luca Pierelli

17.30 - 18.00 Conclusion of ESFH program and Greetings

Remarks Luca Pierelli

*VERIFICA ECM

*Il tempo dedicato alla verifica NON è compreso nelle ore totali del corso

TOTALE ORE DELL’INIZIATIVA FORMATIVA 12 ORE

RAZIONALE

The Societa’ Italiana di Emaferesi e Manipolazione Cellulare (SIdEM) national meeting wiil be held in Florence in a joint fashion with the European Society for Hemapheresis (ESFH). The meeting will deal with attractive and interesting scientific event focused on hemapheresis, cell manipulation and cell therapies. News in this field will be disseminated among participants by international and italian speakers and their expertise will be an exclusive opportunity for stimulating discussions on innovative aspects in the field. The program is planned to have the international ESFH-SIdEM joint meeting on the first two days with common programs and learning sections for physicians and nurses and technicians. Poster and communication sessions will complete this part of the program. The two last days of the meeting will be dedicated to the annual SIdEM adjournment course dealing with non-overlapping topics which will be mainly focused on hemapheresis in specific clinical settings, alternatives to allogeneic transfusions, innovative diagnostics and use of blood components for non trasfusional therapies and regenerative medicine. Also this part of the event will have a common program for physicians and nurse/technicians as well. The general objective of the meeting is that of analyzing in-depth the scentific areas of hemapheresis , cell manipulation and of those aspects of transfusion medicine related to the apheretic therapy and clinical transplantation, combining clinical and methodological aspects that may improve the knowledge of physicians and other professional categories in this innovative field, creating an international and a national scientific context.

A SEGUIRE CURRICULA DOCENZA

Responsabile Scientifico: PIERELLI Luca

PAOLA IUDICONE

Nome PAOLA IUDICONE

E-mail piudicone@scamilloforlanini.rm.it

Nazionalità italiana

Data di nascita 29/06/55

ESPERIENZA LAVORATIVA

Settembre 2009 trasferimento all’Unità di Raccolta Cellule Staminali e Terapie Cellulari dove è attualmente in servizio. Incarico di Alta Professionalità “Manipolazioni Cellulari in Medicina Rigenerativa ed Immunoterapia” Maggio 2007 incarico do Alta Professionalità “Validazione in Biologia Molecolare (NAT) unità di sangue”

1 Dicembre 2002 Trasferimento presso l’ Azienda Ospedaliera. S. Camillo-Forlanini- Servizio Trasfusionale - Laboratorio di Sierologia e Biologia Molecolare Virale in qualità di Dirigente Biologo

Dal 2000 incarico di Vice Capo Reparto e Responsabile del Sistema Qualità del Reparto stesso di Sierologia e Biologia Molecolare Virale.

Aprile 1998, nell’ambito della riorganizzazione dei settori del CNTS è stata trasferita dal Reparto di Immunochimica al Reparto di Sierologia e Biologia Molecolare Virale dello stesso Istituto.

Gennaio 1997 vincitrice di concorso per l’accesso al 1° Livello Differenziato di professionista Biologo dell’area sanitaria.

Luglio 1993 incarico di Responsabile della sezione "Colture Cellulari" del Reparto di Immunochimica.

1 Luglio 1986 assunzione a tempo indeterminato presso il CNTS-CRI Reparto di Immunochimica

Dal 1979 in servizio presso il Centro Nazionale Trasfusione Sangue (CNTS) – Settore Scientifico Didattico della Croce Rossa Italiana (CRI) in qualità di Libero Professionista - Reparto di Immunochimica.

ISTRUZIONE E FORMAZIONE

1978 Laurea con lode in Scienze Biologiche Università degli Studi di Roma La Sapienza con tesi sperimentale in Genetica Umana 1978-1980 Tirocinio post-laurea presso il Reparto di Immunochimica del CNTS-CRI di Roma e presso il laboratorio di Citopatologia dell’Istituto per la Prevenzione dei Tumori di Firenze 1980 iscrizione all’Albo Professionale dei Biologi con N° 12988 1984 Specializzazione con lode in Patologia Generale Università degli Studi di Roma La Sapienza 1995 Diploma in Medicina Trasfusionale Università L. Pasteur di Strasburgo Durante l’attività lavorativa ha curato la sua formazione professionale e il suo aggiornamento partecipando regolarmente a corsi di formazione e convegni nazionali e internazionali inerenti il proprio settore di lavoro.

CAPACITÀ E COMPETENZE

ORGANIZZATIVE

.

Ha ottime capacità organizzative didattiche e di comunicazione. Partecipa attivamente al lavoro di gruppo con competenza e rispetto delle regole; è di stimolo ai colleghi di lavoro di cui incentiva la partecipazione attiva e l’approfondimento delle tematiche oggetto del lavoro. Partecipa all’attività didattica della Scuola Medica Ospedaliera del Lazio, a corsi di formazione ECM sia aziendali che non aziendali, collabora con istituti universitari per la realizzazione di tesi sperimentali. Ha partecipato a diversi progetti di ricerca finanziati dal CNR o dall’ISS e a numerosi Workshop o gruppi di lavoro nazionali e internazionali nei settori specifici di interesse e competenza

CAPACITÀ E COMPETENZE TECNICHE

Ha una buona conoscenza della lingua inglese. Conosce ed utilizza programmi gestionali su piattaforma Office

Ha avuto esperienza pratica nei seguenti settori:

Genetica - presso laboratorio di Genetica Umana- Istituto di Genetica - Università degli Studi di Roma Sapienza

Citopatologia – presso laboratorio di Citopatologia dell’Istituto per la Prevenzione dei Tumori di Firenze Immunologia – presso Reparto di Immunochimica - Centro Nazionale Trasfusionae Sangue della CRI di Roma

Biologia Molecolare – presso Laboratorio di Sierologia e Biologia Molecolare Virale - Centro Nazionale Trasfusione Sangue della CRI di Roma

Trapianto Cellule Staminali – Laboratorio di Cellule Staminali e Terapie Cellulari SIMT A. O. S. Camillo-Forlanini di Roma

. Ha partecipato a numerosi Congressi Nazionali e Internazionali in cui ha presentato oltre 100 estratti inerenti i risultati di lavori scientifici delle diverse attività cui ha partecipato. Ha pubblicato oltre 70 lavori scientifici nei diversi settori in cui ha lavorato.

ALTRE CAPACITÀ E COMPETENZE

ULTERIORI INFORMAZIONI

E’ membro delle seguenti Società Scientifiche:

SIMTI – Società Italiana di Medicina Trasfusionale ed Immunoematologia

SIDEM – Società Italiana di Emaferesi e Manipolazione Cellulare

SCR – Stem Cell Research – Società Italiana per la Ricerca sulle Cellule Staminali

Autorizzo il trattamento dei miei dati personali ai sensi del D.lgs. 196 del 30 giugno 2003. Data_30/10/2013_________ Firma Paola Iudicone

FRANCESCO LANZA C U R R I C U L U M V I T A E

INFORMAZIONI PERSONALI

Nome LANZA FRANCESCO

E-mail f.lanza@ospedale.cremona.it

Nazionalità Italiana

Data di nascita 14 gennaio 1959

ESPERIENZA LAVORATIVA

Date (da – a) Dal 01/08/2009 • Nome e indirizzo del datore di

lavoro

Unità Complessa di Ematologia e Centro Trapianti dell’Azienda Ospedaliera di Cremona.

• Tipo di azienda o settore Azienda Ospedaliera • Tipo di impiego Direttore Unità Complessa

• Principali mansioni e responsabilità Direttore e Primario

• Date (da – a) Dal 1983 al 1988 • Nome e indirizzo del datore di

lavoro

Sezione di Ematologia della Azienda Ospedaliera- Universitaria di Ferrara

• Tipo di azienda o settore Azienda ospedaliera • Tipo di impiego Frequentatore e borsista AIRC

• Principali mansioni e responsabilità Attività clinica e di ricerca

• Date (da – a) Da febbraio 1988 al 1 Agosto 2009 • Nome e indirizzo del datore di

lavoro

Arcispedale S.Anna di Ferrara – Istituto di Ematologia di Ferrara

• Tipo di azienda o settore Azienda Ospedaliera di Ferrara • Tipo di impiego Dirigente medico I livello con qualifica di medico di particolare qualificazione (già

Assistente Medico di ruolo e Aiuto corresponsabile dal 1989). Funzione di responsabilità dell’attività clinica e di laboratorio del trapianto di cellule staminali emopoietiche

• Principali mansioni e responsabilità Medico specialista

• Date (da – a) Da aprile 1986 ad aprile 1987 • Nome e indirizzo del datore di

lavoro

Reparto di Medicina dell’ Ospedale Militare Tipo A di Padova

• Tipo di azienda o settore Ospedale Militare • Tipo di impiego Assistente Medico – Ufficiale di complemento

• Principali mansioni e responsabilità Medico Chirurgo

ISTRUZIONE E FORMAZIONE • Date (da – a) Anno accademico 1986

• Nome e tipo di istituto di istruzione o formazione

Università di Ferrara- Scuola di specializzazione in Ematologia Clinica e di Laboratorio

• Principali materie / abilità professionali oggetto dello studio

Oncologia

• Qualifica conseguita Diploma di specializzazione in Ematologia

• Livello nella classificazione nazionale (se pertinente)

Specializzazione Ematologia Clinica e di Laboratorio

• Date (da – a) Anno accademico 1989

• Nome e tipo di istituto di istruzione o formazione

Università di Ancona- scuola di specializzazione in Oncologia

• Principali materie / abilità Oncologia

professionali oggetto dello studio

• Qualifica conseguita Diploma di specializzazione in Oncologia

• Livello nella classificazione nazionale (se pertinente)

Speciallizzazione

• Date (da – a) Gennaio 1985 – dicembre 1987

• Nome e tipo di istituto di istruzione o formazione

Associazione italiana per la ricerca sul Cancro (A.I.R.C.) Sezione di Ematologia – Ospedale S.Anna Ferrara(Università di Ferrara)

• Principali materie / abilità professionali oggetto dello studio

Ematologia

• Qualifica conseguita Attestazioni di frequenza come medico Borsista

• Livello nella classificazione nazionale (se pertinente)

//

• Date (da – a) Anno accademico 1983

• Nome e tipo di istituto di istruzione o formazione

Università di Ferrara – Corso di laurea in Medicina e Chirurgia

• Principali materie / abilità professionali oggetto dello studio

Anatomia, Fisiologia, Patologia Generale, etc.

• Qualifica conseguita Laurea in Medicina e Chirurgia

• Livello nella classificazione nazionale (se pertinente)

Laurea

CAPACITÀ E COMPETENZE

PERSONALI Acquisite nel corso della vita e della

carriera ma non necessariamente riconosciute da certificati e diplomi

ufficiali.

PRIMA LINGUA Italiano

ALTRE LINGUE

INNGLESE

• Capacità di lettura Inglese ottima

• Capacità di scrittura Inglese buona

• Capacità di espressione orale Inglese buona

PATENTE O PATENTI Patente di guida categoria B

ULTERIORI INFORMAZIONI

Svolge attività di insegnamento presso l’Università di Ferrara, Modena, Verona, e Urbino.

E’ attualmente Presidente della Società Italiana di Citometria (GIC)

Presidente Europeo della “International Society for Cellular Therapy” (ISCT-),

Chairman del Comitato “Qualirty Assessment of Stem Cell Graft ” della Società Europea di Trapianti EBMT.

Svolge funzione di “Associate Editor” della Rivista Internazionale: Cytometry part B (Chicago-US) e della Rivista “Journal of Biological Regulators.

Svolge inoltre attività di coordinamento el Gruppo Europeo “EUROGRAFT”.

Componente di : Standardization Committee on Clinical Flow Cytometry of the International Federation of Clinical Chemistry”

Socio fondatore e già componente del Board Direttivo di “European Society on Clinical Cell Analysis- ESCCA”;

Membro di Advisory Board della Scuola Europea di Citometria, Scuola Nazionale di Citometria.

Il Dr. Lanza ha pubblicato oltre 200 lavori scientifici in riviste internazionali “peer review” (impact factor totale > 800),

25 editoriali e review in Riviste Internazionali.

Speaker ad invito in oltre 280 Congressi Nazionali ed Internazionali.

ALLEGATI File publicazioni e memberschips

Il sottoscritto è a conoscenza che, ai sensi dell’art. 26 della legge 15/68, le dichiarazioni mendaci, la

falsità negli atti e l’uso di atti falsi sono puniti ai sensi del codice penale e delle leggi speciali. Inoltre, il

sottoscritto autorizza al trattamento dei dati personali, secondo quanto previsto dalla Legge 196/03.

Cremona……., il 21.06.2011

Dott. Francesco Lanza (FIRMA)

PAOLO PERSEGHIN

RICCARDO SACCARDI

F O R M A T O E U R O P E O P E R

I L C U R R I C U L U M V I T A E

INFORMAZIONI PERSONALI

Nome RICCARDO SACCARDI

Indirizzo SOD s Banca del Cordone Ombelicale - Padiglione di San Luca Vecchio - AOU Careggi - Largo Brambilla 3 - 51034 Firenze

E-mail riccardo.saccardi@aouc.unifi.it

Nazionalità Italiano

Data di nascita 20/04/1956

ESPERIENZA LAVORATIVA

• Date (da – a) 1985-1989 Gruppo Cooperatore Italiano sulla chemosensibilità. 1987 Visiting Scholar, Bone Marrow Transplant Unit, Hopital S. Louis, Paris. 1988 Visiting Scientist, Bone Marrow Transplant Unit, MSKCC, New York.

1990 -1994 Assistente Medico presso la UO Ematologia, addetto al Reparto Trapianti, Azienda Ospedaliera Careggi, Firenze.

1994→ Dirigente Medico di I livello presso la SOD Ematologia, addetto al Reparto Trapianti, Azienda Ospedaliera Careggi, Firenze.

1995-2001 Membro del Gruppo Italiano Raccolta e Amplificazione Cellule Emopoietiche (GRACE).

1996→ Responsabile medico del Centro Sangue di Cordone Ombelicale 1998-2003 Coordinatore italiano del GITMO-Neuro Intergroup per il Trapianto di Cellule Staminali Emopoietiche nella Sclerosi Multipla

2000-2010 Attività sperimentale nel settore della medicina rigenerativa 2000-2010 Attività sperimentale sullo studio delle cellule staminali mesenchimali 2001-2005 Membro del Consiglio Direttivo GRACE. 2001→ Coordinatore ematologico dello Studio sul Trapianto di

Cellule Staminali Emopoietiche nella Sclerosi Multipla promosso dalla Società Europea per il Trapianto di Midollo Osseo (EBMT)

2001→ Membro del Working Party sulle Malattie Autoimmuni dell EBMT 2008 Scientific Chair del Congresso Annuale dell’EBMT tenutosi a Firenze 2004→ Ispettore JACIE per settore clinico e laboratorio 2004 - 2010 Chairman del Working Party sulle Malattie Autoimmuni dell EBMT 2009 Chair del congresso internazionale “Haematopoietic stem

cell transplantation for Autoimmune Diseases”, tenutosi a Firenze

2010→ Direttore del SODs Banca del Cordone Ombelicale, AOU Careggi, Firenze

2011→2012Direttore Scientifico del progetto “Bancaggio e Trapianto di cellule staminali di cordone ombelicale: analisi del Registro Internazionale Eurocord”, coordinato dal CNT/CNS, AOU Careggi e Eurocord, a Parigi

• Nome e indirizzo del datore di lavoro

• Tipo di azienda o settore Azienda mista Ospedaliera-Universitaria Careggi

• Tipo di impiego Dirigente medico

• Principali mansioni e responsabilità

Direttore del SODs della Banca di Cordone Ombelicale, Dirigente medico SODc Ematologia

ISTRUZIONE E FORMAZIONE

• Date (da – a) 1974 Maturità Classica presso il Liceo Michelangelo di Firenze 1981 Laurea in Medicina e Chirurgia, Presso la Facoltà di Medicina dell’Università di Firenze. Massimo dei voti con Lode. 1984 Specializzazione in Ematologia, Presso la Facoltà di Medicina dell’Università di Firenze. Massimo dei voti con Lode.

PRIMA LINGUA ITALIANO

ALTRE LINGUE INGLESE

• Capacità di lettura eccellente

• Capacità di scrittura eccellente

• Capacità di espressione orale

eccellente

PATENTE O PATENTI SI

Il sottoscritto è a conoscenza che, ai sensi dell’art. 26 della legge 15/68, le dichiarazioni mendaci, la falsità

negli atti e l’uso di atti falsi sono puniti ai sensi del codice penale e delle leggi speciali. Inoltre, il

sottoscritto autorizza al trattamento dei dati personali, secondo quanto previsto dalla Legge 196/03.

CITTA’ ____FIRENZE__________________ DATA_____14/ 01/2014 NOME E COGNOME (FIRMA)

RICCARDO SACCARDI

JEFFREY LAWRENCE WINTERS, M.D. winters.jeffrey@mayo.edu

Sex: male| Date of birth: 07/10/1965| Nationality: United States

WORK EXPERIENCE

August 2001 – present

Consultant, Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo

Clinic, Rochester MN.Professor of Laboratory Medicine and Pathology, Mayo College of Medicine,

Rochester MN.Vice-chair, Division of Transfusion Medicine (2011 - present).Clinical responsibilities

include Medical Director of the Therapeutic Apheresis Unit (2004 - present) as well as attending on the

transfusion medicine service. Additional responsibilities include Associate Program Director of the

Anatomic and Clinical Pathology Residency, Department of Laboratory Medicine and Pathology (2012 -

present), Director of Resident Education and Fellowship Program, Division of Transfusion Medicine

(2004 - present), Director of the Education Resource Team, Division of Transfusion Medicine (2006 -

present), and Blood Bank Technical Director, St. Elizabeth’s Medical Center, Wabasha MN (2009 -

2013). Past responsibilities have included Medical Director of Donor Services (2002 - 2007) and

Associate Medical Director of the Human Cellular Therapy Laboratory (2001 - 2004).

July 1999 – July 2001

Assistant Professor, Department of Pathology and Laboratory Medicine, University of Kentucky College

of Medicine, Lexington, KY. Director of Transfusion Service, Cooper Drive Division of the Veteran’s

Affairs Medical Center; Associate Director of the Blood Bank, University of Kentucky Chandler Medical

Center; and Associate Medical Director, Central Kentucky Blood Center. Additional responsibilities

included attending on the apheresis service and the autopsy service.

EDUCATION AND TRAINING

Doctor of Medicine with High Distinction, University of Kentucky College of Medicine, Lexington, KY

1993.

Bachelor of Science Magna Cum Laude, Centre College, Danville, KY 1988.

June 1998 – June 1999

Fellow, Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo

Clinic, Rochester, MN.Transfusion Medicine fellowship with both blood collection center and transfusion

service training. Responsible for transfusion medicine consultations; pathology resident, medical

laboratory technician student, and medical student teaching; and clinical research projects. Additional

elective experience obtained in apheresis, tissue typing, and coagulation.

July 1993 – June 1998

Resident, Department of Pathology and Laboratory Medicine, University of Kentucky Chandler Medical

Center, Lexington, KY.Anatomic/Clinical pathology residency program. Responsible for lecture,

laboratory, and small group instruction of allied health students; participated on CAP laboratory

accreditation inspection teams; and taught transfusion medicine lectures for hospital housestaff. Fourth

year focused on research supervised by Roger A. Fleischman, M.D., Ph.D. investigating the possible role

of HOX homeobox genes in thrombocytopenia with absent radii (TAR) syndrome and megakaryocyte

development.

HONORS AND AWARDS

Mayo Clinic Division of Transfusion Medicine 2013 American Society for Apheresis Lecturer Award

2012 DLMP Innovation & Leadership in Education Award

2011 Mayo Fellows’ Association Clinical Pathology Teacher of the Year

2009 Mayo Fellows’ Association Clinical Pathology Teacher of the Year

2008 Mayo Clinic Excellence through Teamwork Award

2005 Mayo Fellows’ Association Clinical Pathology Teacher of the Year

2002 American Society for Apheresis Junior Investigator Award

University of Kentucky Department of Pathology and Laboratory Medicine

2001 Department of Pathology and Laboratory Medicine Faculty Teaching Award

1993 American Society of Investigative PathologyConcepts in Molecular Biology Scholarship

University of Kentucky College of Medicine

1993 Albert Benjamin Chandler Award as Class Valedictorian

1993 Merck Manual Award

1992 Alpha Omega Alpha

1991 Irving and Esther Kanner Memorial Award

1990 Pathology Prize

1990 Doris M. Scripture Scholarship

1990 Sandoz Pharmaceuticals Award

1990 ASCP Award for Academic Excellence and Achievement

1988 - 1993 Fouryear recipient of Dean’s Scholarship

Centre College

1988 Phi Beta Kappa

1988 Wilbur Cooke Biological Science Award

1987 Phi Sigma Iota

1984 - 1988 Dean's List for all semesters

1984 - 1988 Four year recipient of Trustee Scholarship and Merit Scholarship

PROFESSIONAL SOCIETY MEMBERSHIPS AND POSITIONS

2012 - American Society of Hematology

2009 American Society of Hematology Alternate Pathway Training Grant Committee

2002 - Minnesota Association of Blood Banks

2004 - 2005 Immediate Past President

2003 - 2004 President

2002 - 2003 Vice President

2001 - 2002 Physician Liaison

2001 - Minnesota Medical Association

2001 - Zumbro Valley Medical Association

1999 - American Society for Apheresis

2013 Scientific co-chair, 2014 ASFA/WAA Joint Congress

2012 - 2013 Liaison, CAP Transfusion Medicine Resource Committee

2011 - 2012 Immediate Past President

2010 - 2011 President

2009 - 2010 President Elect

2008 - 2009 Vice President

2007 - 2008 Treasurer

2006 - 2007 Secretary

2005 - 2006 Director

2011 - Industry Liaison

2010 - Apheresis Physicians Committee

2007 - 2010 Residents and Fellows Training ad hoc Committee

2005 - Apheresis Clinical Applications Committee

2004 - Associate editor, Journal of Clinical Apheresis

2004 - 2005 Chair, American Society for Apheresis Website Committee

2003 - 2005 Scientific co-chair, 2005 ASFA Annual Meeting

2003 - 2005 American Society for Apheresis Education Committee

1995 - American Association of Blood Banks

2010 - Transfusion Medicine Section Coordinating Committee

2007 - Transfusion Medicine and Blood Banking Fellowship Program Directors’

Committee

2010 - Chair

1994 - 2010 American Medical Association

1994 - 2001 Kentucky Medical Association

1999 - 2000 Y2K Physician’s Task Force

1996 - 1998 Kentucky Medical Association Young Physicians Steering Committee

1994 - 2001 Lexington Medical Society

1993 - College of American Pathologists

2014 - Transfusion Medicine Resource Committee

1998 - 2000 College of American Pathologists HL7 voting member

1997 - 2002 College of American Pathologists SNOMED International Editorial Board

1995 - 1997 Delegate to the College of American Pathologists Resident's Forum

1994 - 1995 Alternate Representative to the College of American Pathologists Resident's

Forum

1996 College of American Pathologists Resident's Forum RF-S95-2 ad hoc Committee

1995 College of American Pathologists Resident's Forum Credentials Committee

1993 - American Society for Clinical Pathology

2012 - Transfusion Medicine In-Service/Resident In-Service Exam Committee

2012 - Chair

2011 - 2012 Transfusion Medicine In-Service Exam Committee

2010 - 2012 Pathology Resident In-Service Exam question writer

1993 - 1997 American Society of Investigative Pathology

ALESSANDRO LANTI

ALBERTO BOSI

CHESTER ANDRZEJEWSKI, JR. Transfusion and Apheresis Medicine Services Room C1162 Baystate Medical Center 759 Chestnut Street Springfield, MA 01199 Email: chester.andrzejewski @bhs.org

PROFESSIONAL EXPERIENCE

Medical Director,

Baystate Health Transfusion and Apheresis Medicine Services and Diagnostic Immunology

Laboratory, 1992 - Present

Springfield, MA USA

Attending Physician 1992 - Present

Department of Pathology, Baystate Medical Center

Springfield, MA, USA

Assistant Professor 1993 - Present

Department of Pathology

Tufts University Scholl of Medicine

Boston, MA, USA

EDUCATION

Tufts University School of Medicine M.D.

Boston, MA,USA

Tufts University Ph.D. Immunology

Boston, MA, USA

Brown University Bachelor of Science

Providence, RI, USA

BOARD CERTIFICATION

Diplomate of the National Board of Medical Examiners

Diplomate of the American Board of Pathology Combined Certification in Clinical Pathology

and Blood Banking/Transfusion Medicine

MEDICAL LICENSURE

Massachusetts State

Pennsylvania State

GRADUATE TRAINING

Internship Pathology

Hospital of the University of Pennsylvania, Philadelphia, PA USA

Residency Pathology

Hospital of the University of Pennsylvania, Philadelphia, PA USA

Fellowship Blood Banking/Transfusion Medicine

Hospital of the University of Pennsylvania, Philadelphia, PA USA

PUBLICATIONS

Selected Peer Reviewed Publications:

1. Datta, S.K., Manny, N., Andrzejewski, C., Andre-Schwartz, J. and Schwartz, R.S.

Genetic Segregation of autoimmunity and retrovirus expression in crosses of NZB mice.

I. Infectious Xenotropic Virus. J. Exp. Med. 147: 854-871, 1978.

2. Andrzejewski, C., Jr., Stollar, B.D., Lalor, T.M. and Schwartz, R.S. Hybridoma

autoantibodies to DNA. J. Immunol. 124: 1499-1502, 1980.

3. Andrzejewski, C., Jr., Rauch, J., Lafer, E.M., Stollar, B.D., and Schwartz, R.S. Antigen-

binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to

DNA.J. Immunol. 126: 226-231, 1981.

4. Lafer, E.M., Rauch, J. Andrzejewski, C., Jr., Mudd, D., Furie, B., Schwartz, R.S. and

Stollar, B.D. Polyspecific monoclonal lupus autoantibodies reactive with both

polynucleotides and phospholipids. J. Exp. Med. 153:897-909, 1981.

5. Rauch J, Lafer E, Andrzejewski C, Stollar BD, Schwartz RS. Monoclonal

lupusautoantibodies. Arthritis & Rheumatism. 25(7): 744-746, 1982. Article first

published online:28 NOV 2005. DOI: 10.1002/art.1780250705.

6. Andrzejewski, C., Jr., Gault, E. Briggs, M. and Silberstein, L. The benefit of a 37oC

extracorporeal circuit in plasma exchange therapy for selected cases with cold agglutinin

disease. J. Clin. Aph.4: 13-17, 1988.

7. Andrzejewski, C., Jr., Young, P.J., Goldman, J. Spitalnik, S., and Silberstein, L.

Production of human warm reacting anti-erythrocyte monoclonal autoantibodies by

Epstein-Barr virus transformation.Transfusion.29: 196-200, 1989.

8. Lucey, D., Milum, S., Lindquist, C., Andrzejewski, C., Benton, J., Boswell, R.N. Pseudo-

failure of Zidovudine prophylaxis after an HIV positive needle stick.The Journal of

Infectious Diseases.162: 1211-1212, 1990.

9. Lucey, D., Hendrix, C.W., Andrzejewski, C., Jr., Melcher, G.P., Zajac, R.A., Boswell,

R.N.Hepatitis C antibody in a non-hemophiliac cohort infected with the

humanimmunodeficiency virus.Viral Immunology. 3: 295-301, 1990.

10. Andrzejewski, C., Young, P.J., Cines, D.B., Silberstein, L.E. Heterogeneity of human

anti-erythrocyte autoantibodies assessed by isoelectric focusing. Transfusion.31: 236-244,

1991.

11. Lucey, D.R., Hendrix, C.W., Andrzejewski, C., Melcher, G.P., Butzin, C.A., Wians, F.H.

and Boswell, R.N. Comparison by Race of Total Serum IgG, IgA, and IgM with CD4+ T-

Cell Counts in North American Persons Infected with the Human Immunodeficiency

Virus (HIV-1). Journal of Acquired Immune Deficiency Syndromes.5: 325-332, 1992.

12. Monteleone, P.M., Andrzejewski, C., and Kelleher, J.F.: Prevalence of antibodies to

Hepatitis C Virus in transfused children with cancer. The American Journal of Pediatric

Hematology/Oncology.15(4): 309-313, 1994.

13. Popovsky, M.A., Audet, A.M. and Andrzejewski, C. Transfusion-associated circulatory

overload in orthopedic surgery patients: A multi-institutional study. Immunohematology.

12(2):87-89, 1996.

14. Weinreb, S., Delgado, J.C., Clavijo, O.P., Yunis, E.J., Bayer-Zwirello, L., Polanski, L.,

Deluhery,L., Cohn, G., Yao, J.T., Stec, T.C., Higby, D. and Andrzejewski, C.

Transplantation of unrelatedcord blood cells.Bone Marrow Transplantation.22: 193-196,

1998.

15. Audet, A.M., Andrzejewski, C., and Popovsky, M.A. Red blood cell transfusion practices

in patients undergoing orthopedic surgery: A multi-institutional analysis. Orthopedics,

21(8): 851-858, 1998.

16. Audet, A.M., Andrzejewski, C., and Popovsky, M.A. Improving the appropriateness of

red blood cell transfusions in patients undergoing orthopedic surgery.Evaluation and the

Health Professions.21(4): 487-501, 1998.

17. Webley WC, Salva PS, Andrzejewski C, Cirino F, West CA, Tilahun Y, Stuart ES. The

bronchial lavage of pediatric patients with asthma contains infectious Chlamydia.Am J

Respir Crit Care Med. 171(10): 1083-8, 2005. [Epub ahead of print 25 Feb 2005, DOI

10.1164/rccm.200407-917OC].

18. Andrzejewski C, Popovsky MA. Transfusion-associated adverse pulmonary sequelae:

wideningour perspective. Transfusion, 45(7): 1048-50, 2005.

19. Cirino F, Webley WC, West C, Croteau NL, Andrzejewski C Jr., Stuart ES. Detection

ofChlamydia in the peripheral blood cells of normal donors using in vitro culture,

immunofluorescencemicroscopy and flow cytometry techniques. BMC Infect Dis ; 6:23,

2006;[DOI 10.1186/1471-2334-6-23].

20. Cirino F, Webley WC, West C, Croteau NL, Andrzejewski C Jr., Stuart ES. Correction:

Detectionof Chlamydia in the peripheral blood cells of normal donors using in vitro

culture,immunofluorescence microscopy and flow cytometry techniques. BMC Infect Dis

; 6:165, 2006;[DOI 10.1186/147-2334-6-165].

21. Webley W, Stuart E, Cirino F, Cahill F, Stec T, Andrzejewski C. Successful removal of

Chlamydiapneumoniae from plateletpheresis products collected using automated

leukoreduction Hemapheresis techniques. J Clin Apher 21:195-201, 2006.

[Epub ahead of print 28 March 2006, DOI 10.1002/jca.200086.]

22. Pantanowitz L, Andrzejewski C. Plasma exchange therapy for victims of envenomation:

is thisreasonable? J Clin Apher 21: 215-218, 2006; [Epub ahead of print 21 Apr 2006,

DOI10.1002/jca.20097].

23. Webley WC, Salva PS, Andrzejewski C, Cirino F, West CA, Tilahun Y, Stuart

ES.Correspondence Notice of Duplicate Publication.Am J Respir Crit Care Med. 175: 94,

2007.

24. Henneman, Elizabeth A , George S Avrunin , Lori A Clarke , Leon J Osterweil ,

ChesterAndrzejewski Jr , Karen Merrigan , Rachel Cobleigh , Kimberly Frederick , Ethan

Katz-Bassett,Philip L Henneman. Increasing Patient Safety and Efficiency in Transfusion

Therapy Using FormalProcess Definitions. Transfus Med Rev. 2007 Jan; 21 (1): 49-57.

[DOI 10.1016/j.tmrv.2006.08.007].

25. Webley W, Tilahun Y, Lay K, Stuart ES, Andrzejewski C, Salva PS: Rate of Chlamydia

pneumoniae in paediatric respiratory infections. Eur Respir J. 2009 Feb; 33(2):360-7.

[Epub 2008 Nov 14, DOI 10.1183/090319031936.00019508].

26. Levy R, Pantanowitz L, Cloutier D, Provencher J, McGirr J, Stebbins J, Cronin S, Wherry

J, FentonJ, Donelan E, Johari V, Andrzejewski C. Development of electronic record

charting for hospitalbased transfusion and apheresis medicine services: early adoption

perspectives. J Pathol Inform.2010; 1:8.

27. Agrawal V,Vaidya CK,Ye J,Freeman J, McKiernan C, Blier PR, Andrzejewski, Jr. C,

Germain M,Braden GL. Concomitant thrombotic thrombocytopenic purpura and ANCA-

associated vasculitis inan adolescent.Pediatr Nephrol. 2011;8:1317-20. [Epub 2011 Apr

16;DOI 10.1007/s00467-011-1862-5].

28. Winters JL, Brown D, Hazard E,Chainani A, Andrzejewski, Jr. C.Cost-minimization

analysis of thedirect costs of TPE and IVIg in the treatment of Guillain-Barre syndrome.

Journal: BMC HealthServices Research.2011;MS: 6314405474523010. BMC Health Serv

Res. 2011;11;101.

29. Andrzejewski Jr. C, Popovsky MA, Stec TC, Provencher J, O’Hearn L, Visintainer P, and

SteingrubJ.Hemotherapy bedside biovigilance involving vital sign values and

characteristics of patients withsuspected transfusion reactions associated with fluid

challenges: can some cases of transfusionassociated circulatory overload have

proinflammatory aspects? Transfusion, 52: 2310-20, 2012. E-pub: 11 March 2012. doi:

10.1111/j.1537-2995.2012.03595.x.

30. Marshall C, Andrzejewski C, Carey P, Crookston K, Li Y, Lopez-Plaza I, Sachais B,

Schwartz J,Winters J, Wu YY, Wong E. Milestones for Apheresis. Journal of Clinical

Apheresis, 27: 242-46.2012. E-pub: 06 July 2012. doi:10.1002/jca.21235.

31. Andrzejewski Jr. C, Linz W, Hofman J, O’Doherty U, Robinson RS, Arepally G, Golden

P.American Society for Apheresis White Paper: Considerations for Medical

StaffApheresis Medicine Physician Credentialing and Privileging. Journal of Clinical

Apheresis,27: 330-335. 2012.E-pub: doi: 10.1002/jca.21250.

32. Roderick JE, Gonzalez-Perez G, Kuksin CA, Dongre A, Roberts ER, Srinivasan

L,Andrzejewski C Jr, Fauq AH, Golde TE, Miele L, Minter LM. Therapeutic targeting of

NOTCH-signaling ameliorates immune-mediated bone marrow failure of aplastic anemia.

Journal ofExperimental Medicine. 210(7):1311-1329.2013.

33. Andrzejewski C Jr, Casey MA, Popovsky MA. How we view and approach transfusion

associatedcirculatory overload: pathogenesis, diagnosis, management, mitigation, and

prevention. Transfusion.53:3037-3047.2013. E-pub: 28 October 2013. doi:

10.1111/trf.12454.

MEMBERSHIPS AND ASSOCIATIONS

College of American Pathologists, Fellow, 1992

American Society for Apheresis, 1986

American Association of Blood Banks, 1985

Association of Medical Laboratory Immunologists, 1993

American Society of Hematology, 2000

American Association for Clinical Chemistry, 1994

American Society of Clinical Pathology, 2009

GAIL ROCK, PhD MD FRCP(C) Email :gailrock1@hotmail.com

CITIZENSHIP: Canadian M.D. Cum Laude, University of Ottawa,Canada, FRCPC 1991 Hematopathology, University of Toronto

MEMBERSHIPS: American Association of Blood Banks American Society of Hematology American Society for Apheresis Canadian Hematology Society Canadian Apheresis Group European Society for Haemapheresis International Society of Blood Transfusion

International Society for Hematotherapy and GraftEngineering

International Society of Thrombosis and Haemostasis World Apheresis Association

FELLOWSHIPS AND AWARDS: 2002 Cohn-De Laval Award

World Apheresis Association

2007 President’s Award, American Society for Apheresis

2009 National Achievement Award

Canadian Blood Services

2012 Francis S. Morrison Memorial Lectureship American Society for Apheresis

EMPLOYMENT: 1973 –1974 Ottawa General Hospital Department of Medicine, Emergency Medicine

1974 –1988 Medical Director, Ottawa Centre

Canadian Red Cross, Blood Transfusion Service 1988 – 1989 Private Medical Practice 1990 – 1993 Consultant, Department of Agriculture, Canada

1990 – 1992 Reviewer - New Drug Submissions, Drugs

Directorate, Canada 1992 – 1993 Consultant on Fractionation, Armour

Pharmaceuticals 1991 – 1995 Consultant, Office of the Surgeon General,

Canada 1992 – 1997 Consultant, Department of Vascular Surgery

Ottawa Civic Hospital 1994 – 1995 Drug Reviewer Bureau of Human Prescription Drugs Health Canada 1994 – 1995 Assistant Director, Hematology Laboratories Hospital for Sick Children, Toronto 1995 – 1996 Special Advisor - Hospital Blood Establishments,

Bureau of Biologics, Health Canada 1996 – 1998 Chief, Division of Hematology and Transfusion

Medicine, Ottawa Civic Hospital 1998 – 2005 Chief, Division of Hematology and Transfusion

Medicine, Ottawa Hospital 1980 – 2010 Professor of Pathology, University of Ottawa 2005 – Present Medical Consultant/Private Practice

SUPERVISORY EXPERIENCE: As Medical Director of the Ottawa Centre of the Canadian Red Cross, I was responsible for a team of 90 people who undertook the collection, testing and distribution of blood to 29 Eastern Ontario hospitals. I also directed the research activities of up to 20 scientists and technologists. The centre budget was approximately 6 million dollars.

I have supervised the office staff and acted as Chair of the Canadian Apheresis Group, which manages and organizes the activities of 39 apheresis centres across the country. As Chief of the Division of Hematology and Transfusion Medicine at the Ottawa Hospital, I had overall responsibility for the sections of laboratory hematology, coagulation and the blood bank, at 2 sites of the OHO.

RUTELLA SERGIO Sergio Rutella, M.D. Ph.D., has been awarded the National Habilitation to the position of Associate Professor of

Hematology/Oncology/Rheumatology in December 2013. He is currently Assistant Professor of Hematology at the

Catholic University Med. School in Rome, and Director of the Immunohematology and Blood Transfusion Service

at the IRCCS Bambino Gesù Children's Hospital in Rome, Italy. Dr Rutella is a physician-scientist with a long-term

research experience in the immunological aspects of malignant hematology and in the cellular and molecular

mediators of inflammation. Dr Rutella received his M.D. from the Catholic University of Rome in 1993 (summa

cum laude), followed by residency and fellowship in Hematology in 1997 (with honors) and by a Ph.D. diploma in

Experimental Hematology in 2001 (with honors).

To date, Dr Rutella has published 173 scientific articles (5 editorials, 26 reviews, 124 full-length papers, 18

research letters) and 11 book chapters, mainly in the fields of immune tolerance and inflammation, hematological

malignancies and stem cell transplantation (cumulative I.F. [2012] = 811.256; current H-index = 40) [Google

Scholar]. In 2011, he has been included among the "100 Top Italian Scientists" (area: Hematology and Medicine;

http://www.topitalianscientists.org/Top_italian_scientists_VIA-Academy.aspx). Dr Rutella has gained extensive

experience in the management and appraisal of research staff, and has prepared and submitted successful grant

applications to National funding bodies (Italian Association for Cancer Research, FILAS, Ministry of University and

Scientific Research - MIUR/PRIN). Dr Rutella has given invited seminars at academic institutions in Italy (Univ of

Bologna, Urbino, Milan), France (Burgundy) and the United Kingdom (Univ of Glasgow, Univ of Southampton,

Univ of Oxford) and has lectured at national and international scientific meetings. He served as ad-hoc reviewer for

high-impact scientific journals, in the field of both hematology and immunology, also also for international research

fellowships (Lise Meitner Program, Austrian Science Fund; Research Grants Council, Hong Kong Research

Council; Dutch Cancer Society; Danish Council for Independent Research; Leukemia Lymphoma Research UK;

French National Research Agency (ANR), Programme de Recherche Translationnelle en Santè (PRTS), Association

for International Cancer Research (AICR)) and as external examiner for international PhD programs in Molecular

Medicine (Section of Basic and Applied Immunology; University Vita-Salute San Raffaele, Milan).

Dr Rutella received merit awards in 2011, 2006, 2003 and 2002 from the American Association of Immunologists

for research related to the field of tolerogenic dendritic cells, regulatory T cells and IDO1-driven inflammation, and

a European Commiss Marie Curie Actions Scholarship to attend a ESH-BMTmeeting in 2005. Dr Rutella has

teaching experience at both undergraduate (medical students) and post-graduate level (fellowship programs in hemy

and clinical pathology), with teaching contracts in hematological oncology and stem cell biology at the Catholic

University) and immunology (Nursing School, Univ. of Rome "Tor Vergata"). Dr Rutella's editorial activities

include membership in the advsory editorial board of Current Medicinal Chemistry, IRN Hematology, World

Journal of Stem Cells, American Journal of Translational Research, American Journal of Immunology and World

Journal of Transplantation. He has been Guest Editor of a special issue of Current Medicinal Chemistry on

indoleamine 2,3-dioxygenase in inflammation, autoimmunity and cancer, published in early 2011.

EOIN McGRATH

LOZANO MIGUEL

Full name: Miguel Lozano Date of birth: June 14, 1959 E-mail: mlozano@clinic.ub.es

Education: 1992 Ph.D cum laude. University of Barcelona. Thesis: “Study of low-molecular-

weight-heparin(oid)s, pentasacharide and unfractiona-ted heparin in a in vitro thrombosis model. Effect on platelet deposition and fibrin formation.

1988 Specialist in Hematology and Hemotherapy. Hospital Clínic. Barcelona. 1984 M.D with honors. University of Barcelona.

Employment: 2009- Department of Hemotherapy and Hemostasis. Hospital Clínic. Barcelona.

Chief, Hemotherapy Section.

1992-2009 Department of Hemotherapy and Hemostasis. Hospital Clínic. Barcelona. Staff member.

1992 Medical Director of Immuno AG, Spain. 1990-1991 Research Fellow. Department of Hematology. Utrecht University Hospital. The

Netherlands. 1989 Research Fellow. Department of Hemotherapy and Hemostasis. Hospital Clínic

Barcelona. 1985-1988 Resident in Hematology and Hemotherapy. Hospital Clínic. Barcelona.

Professional Associations. - President of the Apheresis Spanish Group since 2008 - Vice-President of the Spanish Society of Blood Transfusion (2002-2006) - President of the Catalan Society of Blood Transfusion (2000-2003) - Ordinary member of: the Spanish Association of Hematology and Hemotherapy, the

American Association of Blood Banks, the Catalan and Balearic Academy of Medical Sciences, the Spanish Society of Blood Transfusion, the International Society of Blood Transfusion, the American Society for Apheresis, and the European Society for Haemapheresis and Haemotherapy.

National and International Committees: - Chair of Editorial Board of the AABB Press since 2008. - Scientific member of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative,

since 2002 - Member of the Catalan Hemotherapy Commission since 2006 - Member of Editorial Board of the AABB Press between 2003-2008 - Spanish representative in the Council of Europe Committee of Experts on Quality Assurance

in Blood Transfusion Services between 2006-2013. - Member of the Board of Advisors for Transfusion Safety of the Spanish Ministry of Health

between 2002-2013

National and International Meetings - Director/moderator of 20 symposiums in national meetings and in 7 international meetings - 74 Invited conferences in national meetings and 36 in international meetings. - 76 communications to national meetings and 64 communications to international meetings.

Scientific Journals: Member of the editorial boards of

- Transfusion and Apheresis Science since July 2012. - Transfusion Medicine Reviews since January 2013 - Journal of Transfusion Medicine (Poland).since January 2013

Publications - Books: 9 - Book chapters: 20 - Spanish journals: 46 - International journals : 85

International journals (last 5 years). 64. Llufriu S, Castillo J, Blanco Y, Ramió-Torrentà L, Río J, Vallès M, Lozano M, Castellà MD,

Calabia J, Horga A, Graus F, Montalban X, Saiz A. Plasma exchange for severe attacks of CNS

inflammatory demyelination: predictors of improvement at 6 months. Neurology. 2009;

73:949-953. IF: 8,172

65. Tadokoro K, Reesink HW, Panzer S, Chabanel A, Santailler G, Guerin T, Socquet D, David B,

Labrune JL, Lin CK, Tsoi WC, Letowska M, Papis JA, Naniewicz J, Dudziak K, Lachert E, Lozano

M, Schneider K, Snyder EL, Champion MH. International Forum. Problems with irradiators.

Vox Sang 2010; 98:78-84. IF: 2,586

66. Cid J, Escolar G, Lozano M. Prophylactic platelet transfusions. N Engl J Med 2010; 362: 2140.

IF: 53,298

67. Reesink HW, Panzer S, McQuilten ZK, Wood EM, Marks DC, Wendel S, Trigo F, Biagini S,

Olyntho S, Devine DV, Mumford I, Cazenave JP, Rasonglès P, Garraud O, Richard P,

Schooneman F, Vezon G, Al Radwan R, Brand A, Hervig T, Castro E, Lozano M, Navarro L,

Puig L, Almazán C, MacLennan S, Cardigan R, Prowse C. Internation Forum. Pathogen

inactivation of platelet concentrates. Vox Sang 2010, 99; 85-95. IF: 2,856

68. Fernández de Larrea C, Martínez C, Gaya A, López-Guillermo A, Rovira M, , Fernández-Avilés

F, Lozano M, Bosch F, Esteve J, Nomdedeu B, Montserrat E, Carreras E. Salvage

chemotherapy with alternating MINE–ESHAP regimen in relapsed or refractory Hodgkin’s

lymphoma followed by autologous stem-cell transplantation. Ann Oncol 2010; 21: 1211-

1216. IF: 6,425

69. Lozano M, Heddle H, Williamson LM, Wang G, AuBuchon JP, Dumont LJ, for the Biomedical

Excellence for Safer Transfusion (BEST) Collaborative. Practices associated with ABO-

incompatible platelet transfusions: a BEST Collaborative international survey. Transfusion

2010;50:1743-1748. IF: 3,217

70. Carreras E, Fernández-Avilés F, Silva L, Guerrero M, Fernández de Larrea C, Martínez C,

Rosiñol L, Lozano M, Marín P, Rovira M Engraftment syndrome after auto-SCT: analysis of

diagnostic criteria and risk factors in a large series from a single center. Bone Marrow

Transplant. 2010;45:1417-1422. IF: 3,746

71. Fernández de Larrea C, Cofan F, Oppenheimer F, Campistol JM, Escolar G, Lozano M.

Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome

after renal transplantation. Transplantation 2010; 89:903-904. IF: 3,781

72. Cid J, Lozano M. Platelet dose for prophylactic platelet transfusions. Expert Rev Hematol

2010; 3:397-400. IF: 2,382

73. Galan AM, Lozano M, Molina P, Navalon F, Marschner S, Goodrich R, Escolar G. Impact of

pathogen reduction technology and storage in platelet additive solutions on platelet

function. Transfusion 2011; 51: 808-815. IF: 3,217

74. Lozano M, Knutson F, Tardivel R, Cid J, Maymó RM, Löf H, Roddie H, Pelly J, Docherty A,

Sherman C, Lin L, Propst M, Corash L and Chris Prowse. A multi-center study of therapeutic

efficacy and safety of platelet components treated with amotosalen and UVA pathogen

inactivation stored for 6 or 7 days prior to transfusion. Brit J Haematol 2011; 153: 393-401.

IF: 4,941

75. Cid J, Carbassé G, Pereira A, Sanz C, Mazzara R, Escolar G, Lozano M. Platelet transfusions

from D+ donors to D- patients: a 10-year follow-up study of 1014 patients. Transfusion

2011; 51:1163-1169. IF: 3,217

76. Pons-Estel GJ, Salerni GE, Serrano RM, Gomez-Puerta JA, Plasin MA, Aldasoro E, Lozano M,

Cid J, Cervera R, Espinosa G. Therapeutic plasma exchange for the management of

refractory systemic autoimmune diseases: Report of 31 cases and review of the literature.

Autoimmun Rev 2011; 10: 679-684. IF: 6,624

77. Heddle NM, Wu C, Vassallo R, Carey P, Arnold D, Lozano M, Pavenski K, Sweeney J,

Stanworth S, Liu Y, Traore A, Barty R, Tinmouth A, for the BEST Collaborative. Adjudicating

bleeding events in a platelet dose study: impact on outcome results and challenges.

Transfusion 2011; 51: 2304-2310. IF: 3,217

78. Cid J, Lozano M. Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J

Med 2011; 365:2336-2338. IF: 53,298

79. Cid J, Escolar G, Lozano M. Therapeutic efficacy of platelet components treated with

amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of

randomized controlled trials. Vox Sang 2012; 103: 322-330. IF: 2,847

80. Blanco-Molina MA, Lozano M, Cano A, Cristobal I, Pallardo LP, Lete I. Progestin-only

contraception and venous thromboembolism. Thromb Res. 2012; 129: e257-262. IF:

2,440

81. Pallardo LF, Cano A, Cristobal I, Blanco MA, Lozano M, Lete I. Hormonal Contraception and

Diabetes. Clinical Medicine Insights: Women’s Health 2012; 5: 53–63. IF: no

82. Pietersz RN, Reesink HW, Panzer S, Gilbertson MP, Borosak ME, Wood EM, Leitner GC,

Rabitsch W, Ay C, Lambermont M, Deneys V, Sondag D, Compernolle V, Legrand D, Francois

A, Tardivel R, Garban F, Sawant RB, Rebulla P, Handa M, Ohto H, Kerkhoffs JL, Brand A,

Zhiburt E, Cid J, Escolar G, Lozano M, Puig L, Knutson F, Hallbook H, Lubenow N, Estcourt L,

Stanworth S, Murphy MF, Williams L, Mraz DL, Ross RL, Snyder E. Prophylactic platelet

transfusions. Vox Sang 2012. Vox Sang. 2012; 103:159-176. IF: 2,847

83. Cid J, Elena M, Diekamn F, Lozano M. Haptoglobin is present in albumin used as a

replacement solution for plasma exchange. Transfusion 2013, 53: 757 - 760. IF: 3,217

84. Caballo C, Escolar G, Diaz-Ricart M, Lopez-Vílchez I, Lozano M, Cid J, Pino M, Beltrán J,

Basora M, Pereira A, Galan AM. Impact of experimental haemodilution on platelet function,

thrombin generation and clot firmness: effects of different coagulation factor concentrates.

Blood Transf 2013; 11: 391- 399. IF: 2,099

85. Rovira J, Cid J, Gutiérrez-García G, Pereira A, Fernández-Avilés F, Rosiñol L, Martínez C,

Carreras E, Urbano A, Rovira M, Lozano M. Fatal immune hemolytic anemia following

allogeneic stem-cell transplantation: report of two cases and review of literature. Transf

Med Rev 2013; 27: 166-70. IF: 3,759

86. Lozano M, Cid J. Analysis of reasons for not implementing pathogen inactivation for platelet

concentrates. Transfus Clin Biol. 2013; 20: 158-64. IF: 0,643

87. Lozano M, Cid J. DEHP plasticizer and blood bags: challenges ahead. ISBT Science Series

2013; 8: 127–130. IF: no

88. Lozano M, Cid J. Pathogen inactivation: coming of age. Curr Opin Hematol 2013; 20:540-

545. IF: 4,111

89. Dzik WH, Beckman N, Murphy MF, Delaney M, Flanagan P, Fung M, Germain M, Haspel RL,

Lozano M, Sacher R, Szczepiorkowski Z, Wendel S, from Biomedical Excellence for Safer

Transfusion Collaborative. Factors affecting RBC storage age at the time of transfusion.

Transfusion 2013; 53: 3110-3119. IF: 3,526

90. Lozano M, Cid J, Müller TH. Plasma treated with methylene blue and light: clinical efficacy

and safety profile. Transf Med Rev 2013; 27: 235-240 IF: 3,759

91. Lozano M, Cid J, Areal C, Romon I, Muncunill J, for the Spanish Apheresis Group. Transfus

Apher Sci 2013; 49: 560-564. IF: 1,225

92. Blasi A, Caballo C, Galán AM, Taura P, Beltran J, Escolar G, Lozano M. The addition of

MESNA in vitro prolongs prothrombin time similar to N-acetyl cysteine. Clin Chem Lab Med.

2013; 51: e297-9. IF: 3,009

93. Cid J, Magnano L, Molina P, Díaz-Ricart M, Martinez N, Maymó RM, Puig L, Lozano M,

Escolar G, Galán AM. Automated preparation of whole blood-derived platelets suspended

in two different platelet additive solutions and stored for 7 days. Transfusion 2014;54:426-

433. IF: 3,526

94. Lozano M, Mahon A, van der Meer PF, Sanworth S, Cid J, Devine D, Fung MK, de la Salle B,

Heddle NM, on behalf of Biomedical Excellence for Safer Transfusion (BEST) collaborative.

Counting platelets at transfusión threshold levels; impacto n the decisión to transfuse. A

BEST Collaborative – UK NEQAS(H) international exercise. Vox Sang 2014 in Press IF:

2,847

95. van der Meer PF, Reesink HW, Panzer S, Wong J, Ismay S, Keller A, Pink J, Buchta C,

Compernolle V, Wendel S, Biagini S, Scuracchio P, Thibault L, Germain M, Georgsen J, Begue

S, Dernis D, Raspollini E, Villa S, Rebulla P, Takanashi M, de KD, Lozano M, Cid J, Gulliksson

H, Cardigan R, Tooke C, Fung MK, Luban NL, Vassallo R, Benjamin R. Should DEHP be

eliminated in blood bags? Vox Sang 2014 in press. IF: 2,847

96. Cid J, Magnano L, Lozano M. Automation of blood component preparation from whole

blood collections. Vox Sang 2014, in press IF: 2,847

BORIS CALMELS

INFANTI JOHN, LAURA

Name

Infanti John, Laura

Date of birth

05/31/1967

Nationality

Italy, Switzerland

Specialty Specialization in Hematology (Italy 1998 and Switzerland 2003) Master in Transfusion and Transplantation Science, University of Bristol, 2009-2010 Specialization in diagnostic Hematology (Switzerland, FAMH) 2009-2012

Present professional position Since 01/01/2008 Deputy Head of Blood Donor Centre and Transfusion Medicine of Swiss Red Cross, Basel Routine diagnostic activity in the hematology laboratory, University Hospital, Basel Routine clinical activity, Clinic of Hematology, University Hospital, Basel 5/15/2007 – 12/31/2007 Head ad interim of Blood Donor Centre and Transfusion Medicine of Swiss Red Cross, Basel

Professional experience In Switzerland: 04/01/1999 – 06/30/2004 medical assistant at the Department of Internal Medicine, University Hospital Basel 05/01/1999 – 03/31/2001 medical assistant at the Ward of Internal Medicine and Geriatrics, Community Hospital, Riehen (from 01/01/2000 to 03/31/2000 full time occupation) 01/04/1999 – 03/31/1999: medical assistant at the Department of Internal Medicine, University Hospital, Basel 11/01/1997 – 05/30/1998: visiting Doctor at the Bone Marrow Transplantation Unit, Department of Internal Medicine, University Hospital, Basel. In Italy: From November 1994 to October 1997 attending Fellowship in Hematology at the Division of Hematology, University of Udine, School of Medicine; From May 1995 to October 1997 working in particular on clinical aspects of stem cell harvesting and transplantation. 01/01/1994 - 11/01/1994: Visiting Doctor at the Division of Hematology, University of Udine, School of Medicine.

November 1991 to November 1993: resident in Internal Medicine at University of Trieste, School of Medicine.

Education 1981 - 1986: High School in Udine (Liceo classico)

1986 - 1988: Study at the Facoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Rome 1988 - 1993: Study at the Facoltà di Medicina e Chirurgia, Università degli Studi, Triest; Graduation and final examination

Other experiences 1992-1998: medical teacher for the Italian Red Cross 1992 - 1998: referee at international First Aid Competition 2000: translator of management texts from German into Italian for the enterprise GFO, Zürich 2000-2009: translator of medical texts from German into Italian for the REHAB Basel

Languages Italian: native language German: very good knowledge (spoken and written language) English: very good knowledge (spoken and written language)

Z.M. SZCZEPIORKOWSKI

RAINER MOOG

Prof. Dr. Rainer Moog

Office address: German Red Cross Blood Donor Service North-East

Thiemstrasse 105, 03050 Cottbus, Germany

Phone +493554995101

Fax +493554995103

e-mail: r.moog@blutspende.de

1986 full medical registration

since V/1987 residency, Institute for Transfusion Medicine, University

Clinics Essen

1988 doctoral thesis at the University of Essen (MD)

1996 board certification in Transfusion Medicine

2000 master thesis for Transfusion Medicine (PhD)

V/2000 - II/2002 associate professor in Transfusion Medicine at the University

Clinics Essen

2003 – 2006 head of R & D Karl-Landsteiner Foundation of the German Red Cross

Transfusion Service West

2006 full professorship

VIII/2006 – IX/2008 interim director of the Institute for Transfusion Medicine, University

Clinics Essen

2007 board certification haemostaseology

X/2008 –XII/2009 head of Munich Blood Bank

2010 - 2013 head of blood transfusion service of hospital laboratory network

Brandenburg-Berlin

head of Institute Cottbus of German Red Cross Transfusion Blood Service North East